Volume 17, Number 11—November 2011
CME ACTIVITY - Research
Global Distribution and Epidemiologic Associations of Escherichia coli Clonal Group A, 1998–2007
Table 5
Method, type of model, variable† | OR (95% CI) | p value |
---|---|---|
GEE‡ | ||
Univariable | ||
TMP/SMZ resistance | 3.90 (2.04–7.46) | <0.001 |
Africa/Asia | 0.39 (0.18–0.89) | 0.02 |
Logistic regression | ||
Univariable | ||
TMP/SMZ resistance | 4.14 (2.74–6.26) | <0.001 |
Africa/Asia | 0.43 (0.26–0.69) | <0.001 |
Multivariable | ||
TMP/SMZ resistance | 3.95 (2.62–5.96) | <0.001 |
Africa/Asia | 0.47 (0.30–0.76) |
0.002
*TMP/SMZ, trimethoprim/sulfamethoxazole; OR, odds ratio; CI, confidence interval; GEE, generalized estimating equation.
*TMP/SMZ, trimethoprim/sulfamethoxazole; OR, odds ratio; CI, confidence interval; GEE, generalized estimating equation. |
*TMP/SMZ, trimethoprim/sulfamethoxazole; OR, odds ratio; CI, confidence interval; GEE, generalized estimating equation.
†Univariable models, but not multivariable models, included the following as candidate predictor variables, each of which yielded a p value >0.10: specimen type (urine vs. nonurine), host age group (<18 vs. >18), host hospital status (inpatient vs. outpatient), local prevalence of TMP/SMZ resistance, and year isolate obtained.
‡ Because the multivariable GEE model that used TMP/SMZ phenotype and Africa/Asia as candidate predictor variables could not run to completion, logistic regression analysis was used instead.
1Investigators who contributed data are listed at the end of this article.